California Public Employees Retirement System Trims Holdings in Kenvue Inc. $KVUE

California Public Employees Retirement System reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 11.1% during the 1st quarter, Holdings Channel.com reports. The firm owned 3,607,466 shares of the company’s stock after selling 452,671 shares during the quarter. California Public Employees Retirement System’s holdings in Kenvue were worth $62,193,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of KVUE. Ceera Investments LLC boosted its position in Kenvue by 4.4% during the first quarter. Ceera Investments LLC now owns 156,874 shares of the company’s stock worth $2,705,000 after acquiring an additional 6,625 shares during the last quarter. Heartland Bank & Trust Co lifted its stake in shares of Kenvue by 9.2% during the 1st quarter. Heartland Bank & Trust Co now owns 12,261 shares of the company’s stock worth $211,000 after purchasing an additional 1,037 shares during the period. Advisortrust Partners LLC boosted its holdings in shares of Kenvue by 12.8% during the first quarter. Advisortrust Partners LLC now owns 21,277 shares of the company’s stock worth $367,000 after purchasing an additional 2,413 shares during the last quarter. Assetmark Inc. grew its position in shares of Kenvue by 5.3% in the first quarter. Assetmark Inc. now owns 72,967 shares of the company’s stock valued at $1,258,000 after purchasing an additional 3,642 shares during the period. Finally, Bessemer Group Inc. increased its stake in Kenvue by 0.4% in the first quarter. Bessemer Group Inc. now owns 8,525,023 shares of the company’s stock valued at $146,972,000 after purchasing an additional 33,680 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.59% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on KVUE shares. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a report on Sunday, July 12th. UBS Group upped their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday. Finally, Barclays cut their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $19.50.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $18.94 on Monday. The firm has a market capitalization of $36.37 billion, a PE ratio of 22.28, a P/E/G ratio of 1.44 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The business has a 50-day moving average of $18.20 and a two-hundred day moving average of $17.86. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.87.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $0.24 EPS. As a group, research analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.